CLASS I ONGOING Device recall · Reported 17 May 2023 · FDA Enforcement Report

Angioguard RX / XP Emboli Capture Guidewire System recalled by Cordis US

Cordis US is recalling Angioguard RX / XP Emboli Capture Guidewire System. The recall was initiated on 24 Mar 2023 and the FDA has classified it as Class I.

Check your package

Lot, batch or date codesUDI/DI 20705032056943; Lot Numbers: 35265335, 35264202
Quantity recalled146 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1487-2023
FDA event ID
91922
Recalling firm
Cordis US, Miami Lakes, FL
Classification
Class I
Status
Ongoing
Recall initiated
24 Mar 2023
FDA classified
11 May 2023
Reported
17 May 2023
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

24 Mar 2023Recall initiated by company
11 May 2023Classified by FDA+48 days
17 May 2023Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

There is a potential for separation of the ANGIOGUARD RX / XP delivery system and capture sheath which include but are not limited to situations of an intra-procedural delay, unplanned percutaneous or surgical intervention, or stroke; while a replacement device is prepared.

Product as listed by the FDA

ANGIOGUARD RX / XP Emboli Capture Guidewire System, REF 801814RMC

Where it was distributed

Worldwide distribution.

Questions about this recall

Why was it recalled?

There is a potential for separation of the ANGIOGUARD RX / XP delivery system and capture sheath which include but are not limited to situations of an intra-procedural delay, unplanned percutaneous or surgical intervention, or stroke; while a replacement device is prepared.

Which lots are affected?

UDI/DI 20705032056943; Lot Numbers: 35265335, 35264202

Where was it sold?

Worldwide distribution.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class I mean?

Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

13 other products · FDA event 91922

This product is part of a recall event; the main page for the event is Angioguard RX / XP Emboli Capture Guidewire System recalled by Cordis US.

More recalls from Cordis US

All 22

Other Heart & Vascular Devices recalls

All 6,199